ResMed Inc. (ASX:RMD)
Australia · Delayed Price · Currency is AUD 37.82
+0.32 (0.85%)
At close: Dec 2, 2025
ResMed Market Cap
ResMed has a market cap or net worth of 55.34 billion as of December 2, 2025. Its market cap has increased by 3.97% in one year.
Market Cap
55.34B
Enterprise Value
54.52B
Revenue
7.95B
Ranking
n/a
PE Ratio
25.46
Stock Price
37.82
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 53.86M to 55.34B, an increase of 102,642.67%. That is a compound annual growth rate of 25.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 55.34B | 1.98% |
| Dec 31, 2024 | 54.27B | 46.20% |
| Dec 29, 2023 | 37.12B | -17.49% |
| Dec 30, 2022 | 44.98B | -14.11% |
| Dec 31, 2021 | 52.37B | 31.17% |
| Dec 31, 2020 | 39.93B | 25.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 89.97B |
| Pro Medicus | 27.85B |
| Cochlear | 18.25B |
| Sonic Healthcare | 11.53B |
| Ramsay Health Care | 8.46B |
| Ansell | 5.37B |
| Telix Pharmaceuticals | 5.16B |
| Mesoblast | 3.48B |